Table 3 Summary statistics of FOI phases 1-3 and PMV at baseline, w6, w12, w24 and w52
N | Median (min-max, IQR) | p-value | |
|---|---|---|---|
Phase 1 | |||
Baseline | 28 | 1.5 (0–16, 9.25) | |
w6 | 27 | 1.0 (0–12, 3.00) | 0.069 |
w12 | 28 | 0.5 (0–46, 3.00) | 0.171 |
w24 | 27 | 0.0 (0–10, 3.00) | 0.004 |
w52 | 18 | 0.0 (0–13, 1.75) | 0.091 |
Phase 2 | |||
Baseline | 28 | 19.5 (0–36, 14.50) | |
w6 | 27 | 19.0 (0–43, 13.50) | 0.451 |
w12 | 28 | 19.0 (0–50, 13.25) | 0.071 |
w24 | 27 | 15.0 (1–48, 15.50) | 0.310 |
w52 | 18 | 19.0 (0–35, 12–75) | 0.256 |
Phase 3 | |||
Baseline | 28 | 1.0 (0–20, 3.75) | |
w6 | 27 | 2.0 (0.22, 3.50) | 0.501 |
w12 | 28 | 2.5 (0–32, 6.25) | 0.089 |
w24 | 27 | 1.0 (0–17, 3.00) | 0.191 |
w52 | 18 | 0.5 (0–12, 2.00) | 0.959 |
PMV | |||
Baseline | 28 | 5.0 (0–27, 7.00) | |
w6 | 27 | 8.0 (0–25, 7.00) | 0.018 |
w12 | 28 | 5.5 (0–36, 9.25) | 0.472 |
w24 | 27 | 7.0 (0–23, 8.50) | 0.204 |
w52 | 18 | 5.5 (0–23, 5.75) | 0.717 |